PMID- 30900509 OWN - NLM STAT- MEDLINE DCOM- 20190812 LR - 20200309 IS - 1744-8069 (Electronic) IS - 1744-8069 (Linking) VI - 15 DP - 2019 Jan-Dec TI - Effects of matrix metalloproteinase inhibitors on N-methyl-D-aspartate receptor and contribute to long-term potentiation in the anterior cingulate cortex of adult mice. PG - 1744806919842958 LID - 10.1177/1744806919842958 [doi] LID - 1744806919842958 AB - Matrix metalloproteinases (MMPs) have been suggested to contribute to long-term potentiation, behavioral learning, and memory. In the dorsal horn of spinal cord, MMPs were reported to contribute to injury-related changes, and inhibitors of MMPs have been proposed as potential analgesics. However, it is unclear whether MMP inhibitors produce these effects by inhibiting the function of N-methyl-D-aspartate receptor (NMDAR), a key receptor for the induction of long-term potentiation. In this study, we wanted to examine if MMP inhibitors affect NMDAR-mediated excitatory postsynaptic currents in the anterior cingulate cortex of adult mice. Among different subtype inhibitors we used, we found that MMP-9 and MMP-2/9 inhibitors did not change NMDAR-mediated excitatory postsynaptic currents. However, MMP-3 and broad-spectrum MMP inhibitors reduced the NMDAR-mediated excitatory postsynaptic currents. Consistently, MMP-9 and MMP-2/9 inhibitors had no effect on NMDAR-dependent long-term potentiation, but MMP-3 and broad-spectrum MMP inhibitors inhibited the induction of long-term potentiation. Our results suggest that MMP inhibitors may produce their effects by inhibiting NMDAR functions in central synapses. FAU - Matsuura, Takanori AU - Matsuura T AD - 1 Center for Neuron and Disease, Frontier Institutes of Science and Technology, Xi'an Jiaotong University, Xi'an, China. AD - 2 Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. AD - 3 Department of Orthopedics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. FAU - Li, Xu-Hui AU - Li XH AD - 1 Center for Neuron and Disease, Frontier Institutes of Science and Technology, Xi'an Jiaotong University, Xi'an, China. AD - 2 Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. FAU - Tao, Chen AU - Tao C AUID- ORCID: 0000-0003-1956-0553 AD - 1 Center for Neuron and Disease, Frontier Institutes of Science and Technology, Xi'an Jiaotong University, Xi'an, China. FAU - Zhuo, Min AU - Zhuo M AUID- ORCID: 0000-0001-9062-3241 AD - 1 Center for Neuron and Disease, Frontier Institutes of Science and Technology, Xi'an Jiaotong University, Xi'an, China. AD - 2 Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. LA - eng GR - PJT-148648/CIHR/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Mol Pain JT - Molecular pain JID - 101242662 RN - 0 (Matrix Metalloproteinase Inhibitors) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) RN - EC 3.4.24.24 (Matrix Metalloproteinase 2) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) MH - Animals MH - Gyrus Cinguli/drug effects/*metabolism MH - Long-Term Potentiation/*drug effects/*physiology MH - Male MH - Matrix Metalloproteinase 2/metabolism MH - Matrix Metalloproteinase 3/metabolism MH - Matrix Metalloproteinase 9/metabolism MH - Matrix Metalloproteinase Inhibitors/*pharmacology MH - Mice MH - Mice, Inbred C57BL MH - Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors/*metabolism PMC - PMC6480992 OTO - NOTNLM OT - Matrix metalloproteinase OT - N-methyl-D-aspartate receptor OT - anterior cingulate cortex OT - long-term potentiation EDAT- 2019/03/23 06:00 MHDA- 2019/08/14 06:00 PMCR- 2019/04/23 CRDT- 2019/03/23 06:00 PHST- 2019/03/23 06:00 [pubmed] PHST- 2019/08/14 06:00 [medline] PHST- 2019/03/23 06:00 [entrez] PHST- 2019/04/23 00:00 [pmc-release] AID - 10.1177_1744806919842958 [pii] AID - 10.1177/1744806919842958 [doi] PST - ppublish SO - Mol Pain. 2019 Jan-Dec;15:1744806919842958. doi: 10.1177/1744806919842958.